Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Broncus HoldingBRNHF 43 Current Ratio is 22.70 as of Dec. 2025, which is at its 10-year median of 22.70. GuruFocus rates BRNHF with a GF Score™ of 43/100. The stock has 7 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Broncus Holding ranks better than 98.71% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Broncus Holding's current ratio for the quarter that ended in Dec. 2025 was 22.70.
Broncus Holding has a current ratio of 22.70. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Broncus Holding's Current Ratio or its related term are showing as below:
BRNHF'
s Current Ratio Range Over the Past 10 Years
Min: 0.64 Med: 22.7 Max: 27.35
Current: 22.7
During the past 7 years, Broncus Holding's highest Current Ratio was 27.35. The lowest was 0.64. And the median was 22.70.
BRNHF's Current Ratio is ranked better than 98.71% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs BRNHF: 22.70
Broncus Holding (OTCPK:BRNHF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Broncus Holding Current Ratio Related Terms
Broncus Holding Current Ratio Historical Data
* Premium members only.
The historical data trend for Broncus Holding's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Broncus Holding's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Broncus Holding Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Broncus Holding's Current Ratio distribution charts can be found below:
* The bar in red indicates where Broncus Holding's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Broncus Holding (BRNHF) has a Current Ratio of 22.70 as of Dec. 2025. This is near median its historical median of 22.70. Over the past decade, Broncus Holding's Current Ratio has ranged from 0.64 to 27.35. According to the industry distribution chart, Broncus Holding ranks #11 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 1.3%.
Is Broncus Holding's Current Ratio too high?
Broncus Holding's current Current Ratio of 22.70 is near median its 10-year median of 22.70. Over the past 10 years, this metric has ranged from a low of 0.64 to a high of 27.35. The Medical Devices & Instruments industry median Current Ratio is 2.49. Broncus Holding's value of 22.70 is 811.6% above this industry median. Based on the distribution chart, Broncus Holding ranks #11 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Broncus Holding has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Broncus Holding's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Broncus Holding ranks #11 out of 852 companies for Current Ratio. This places Broncus Holding in the top 1% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.49. Broncus Holding's value of 22.70 is 811.6% above this benchmark. Historically, Broncus Holding's own Current Ratio has ranged from 0.64 to 27.35 over the past decade. While the company's 10-year median is 22.70 vs. the industry median of 2.49, Broncus Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Broncus Holding's current Current Ratio of 22.70 is 811.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Broncus Holding's current Current Ratio is 22.70, which is near median its own 10-year median of 22.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Broncus Holding stock overvalued right now?
Broncus Holding (BRNHF) has a current Current Ratio of 22.70. The current Current Ratio is 22.70, which is near median its 10-year median of 22.70 and 811.6% above the Medical Devices & Instruments industry median of 2.49. Broncus Holding's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Broncus Holding (BRNHF), the current Current Ratio is 22.70 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD. Geographically, the company operates in Chinese Mainland; European Union; and Other Regions.
43GF Score
Get the complete analysis for BRNHF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRNHF has been successfully added to your 
